U.S. Markets closed

Alimera Sciences, Inc. (ALIM)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
1.38+0.01 (+0.73%)
At close: 4:00PM EDT
People also watch
PSDVACRXANTHAPRIEVOK
Full screen
Previous Close1.37
Open1.36
Bid1.20 x 600
Ask1.55 x 500
Day's Range1.36 - 1.39
52 Week Range1.01 - 2.40
Volume150,341
Avg. Volume387,106
Market Cap89.56M
Beta2.79
PE Ratio (TTM)-2.77
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube8 days ago

    ETFs with exposure to Alimera Sciences, Inc. : June 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
    Capital Cube11 days ago

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Alimera Sciences, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Ophthotech Corp., pSivida Corp., Mateon Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., Insmed Incorporated, Eleven Biotherapeutics, Inc. and Aerie Pharmaceuticals, Inc. (OPHT-US, PSDV-US, MATN-US, REGN-US, INSM-US, ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of ALIM earnings conference call or presentation 9-May-17 12:00pm GMT

    Q1 2017 Alimera Sciences Inc Earnings Call